VXRT 8-K 2026-11-05

Vaxart, Inc. (VXRT) 8-K dated 2026-11-05 — accession 0001437749-26-035275.

Vaxart, Inc. (VXRT) is a biotechnology company listed on US.

Vaxart, Inc. filed a 8-K on 2026-11-05. Accession 0001437749-26-035275.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported VXRT revenue for 2025-12-31 was $237.3M. Net income was $16.3M. Revenue was up 726.7% from 2024-12-31 to 2025-12-31. VXRT currently screens at market cap $73.0M.

Not investment advice. The VXRT SEC hub lists recent forms. The stock page is the research view.